Home | About us | Editorial board | Search | Ahead of print | Current issue | Archives | Submit article | Instructions | Subscribe | Contacts | Advertise | Login 
Search Article 
Advanced search 
  Users Online: 518 Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  

    Article Cited by others


Incretin response in Asian type 2 diabetes: Are Indians different?

Singh Awadhesh Kumar

Year : 2015| Volume: 19| Issue : 1 | Page no: 30-38

   This article has been cited by
1 Effect of race and ethnicity on vildagliptin efficacy: A pooled analysis of phase II and III studies
Plamen Kozlovski,Marilia Fonseca,Viswanathan Mohan,Valentina Lukashevich,Masato Odawara,Päivi M. Paldánius,Wolfgang Kothny
Diabetes, Obesity and Metabolism. 2017;
[Pubmed]  [Google Scholar] [DOI]
2 Ethnic Difference in the Pharmacodynamics-efficacy Relationship of Dipeptidyl Peptidase-4 Inhibitors Between Japanese and non-Japanese Patients: A Systematic Review
Y Ito,K Ambe,M Kobayashi,M Tohkin
Clinical Pharmacology & Therapeutics. 2017;
[Pubmed]  [Google Scholar] [DOI]
3 From organophosphate poisoning to diabetes mellitus: The incretin effect
D. Rathish,S.B. Agampodi,M.A.C.S. Jayasumana,S.H. Siribaddana
Medical Hypotheses. 2016; 91: 53
[Pubmed]  [Google Scholar] [DOI]
4 Frailty and geography: should these two factors be added to the ABCDE contemporary guide to diabetes therapy?
Ernesto Maddaloni,Luca DćOnofrio,Paolo Pozzilli
Diabetes/Metabolism Research and Reviews. 2016; 32(2): 169
[Pubmed]  [Google Scholar] [DOI]
5 Factors Related to the Glucose-Lowering Efficacy of Dipeptidyl Peptidase-4 Inhibitors: A Systematic Review and Meta-Analysis Focusing on Ethnicity and Study Regions
Kayo Fujita,Masayuki Kaneko,Mamoru Narukawa
Clinical Drug Investigation. 2016;
[Pubmed]  [Google Scholar] [DOI]
6 Type 2 diabetes in migrant south Asians: mechanisms, mitigation, and management
Naveed Sattar,Jason M R Gill
The Lancet Diabetes & Endocrinology. 2015; 3(12): 1004
[Pubmed]  [Google Scholar] [DOI]


Read this article